Executive Director, Portfolio & Product Strategy Theranostics

Job Description Summary

The Executive Director, Product Strategy Lead (PSL) will lead the creation, implementation,
orchestration and measurement of the integrated product strategies for an indication of a product within a given therapeutic area in the US, under the leadership of a General Manager for the Prod-uct or Portfolio. This individual will contribute to the key decision making for maximizing the impact of the product under their remit while actively and appropriately managing resource allocation across multiple teams, and multiple functions. This will be done in consultation with various teams and
functions, including Marketing, Sales, Novartis Patient Support, Market Access, Insights and
Decision Science and Medical about their respective strategies, plans and proposed resourcing.
This leader will impact the Novartis legacy in his/her responsibility for accelerating impact in the product/while leading through a business-critical transformation.

This role will contribute to the management of the full P&L for the assigned product, under the final leadership of the General Manager for the Product or Portfolio and will partner closely with functional heads for decision-making of resource allocation to deliver the most accelerated impact for the
product.

This leader will be a key member of the General Manager team in the Integrated Product Strat-egy Organization and is expected to demonstrate accountability for the assigned product or
indication and responsibility for broader enterprise leadership in their decisions and engagement across the US Pharma organization.

This leader has a passion for transformational enterprise leadership, decisive strategy in service of delivering higher impact for patients, customers, healthcare systems with higher quality, speed and agility. Additionally, this leader will be responsible for ensuring that customer engagement and relationship building are factored into the product/ indications’ strategic approach and performance metrics to optimize the approach and identify potential areas of risk.

 

Job Description

Key Responsibilities:

• Perform strategic assessments of select competitor activities, including market situation analysis, strategic forecasting, strategic and operational benchmarking, articulation of implications and drive development of a cross-functional competitive response plan in legal and compliant manner.
• Monitor/benchmark strategic plans and key developments of competitors to provide early warning for potential threats and opportunities for successful implementation of prioritized critical initiatives and tactical plans.
• Proactive surveillance of core Disease Area healthcare & macroeconomic environment including policy, regulatory, health technology to identify threats and opportunities relevant to planning initiatives in the US and identify business critical trends in advance to drive portfolio growth in the future.
• Drive the design and execution of competitive planning initiatives (competitive simulations) for key products subject to significant competitive events. Ensure the effective implementation and integrity of all competitive and business intelligence activities such as primary research, and other appropriate intelligence gathering and analysis projects through timely and appropriate coordination with team members and external vendors.
• Lead strategic planning for lifecycle management (LCM) across the Therapeutic Area portfolio with focus on maximizing the long-term value of our assets
• Work closely with cross-functional teams including Medical Affairs, Development, Strategy & Growth, Novartis Technical Operations, Regulatory, Finance, Supply Chain, Trade and Market Access to ensure realization of LCM priorities. Proactively address/manage risks and issue escalation. Ensure close coordination with peers and key matrix partners, on forecasts and cost projections and appropriate coordination with team members, and external vendors
• Liaison with key cross-functional partners such as Market Access, Medical, BD&L, M&A, Biomedical Research, Development and S&G teams to develop US go/no-go position and critical success factors on pipeline assets
• Inform commercial implications to early asset development plans, as well as drive development of US-centric commercialization strategy for assets in later stages (pre-FDP) to inform strategic product profile development and ensure transition to established IPSTs as appropriate.
• Strong relationship with International TA to ensure that commonalities can be maximized, and differences can be elevated for appropriate discussion.
• Develop center of excellence capabilities within the team

Essential Requirements:

Education (minimum/desirable):

Bachelor's Degree is